Drug Pipeline

Drug Pipeline Market Research Reports

Drug Pipeline Market Research Reports Analysis and Trends

Discovering and bringing new drugs to main stream commercial market typically takes an average of 10-15 years of research and clinical development efforts. Drug developers need to make sure safe and effective drug available for patient in quick time. The first step is target the protein available in patient’s body which are associated to microorganism causing a disease, through tracking of cellular network of proteins an appropriate target for drug is selected. Through series of trials right drug candidate got chosen.
Acute Renal Failure (ARF) (Acute Kidney Injury) - Market Insight, Epidemiology and Market Forecast - 2027

Report estimates the market Size of Acute Renal Failure is expected to reach up to USD 8,702 million in the year 2027.

 

Find More

According to “NOVARTIS”, bringing a new drug in market takes 14 years of research and cost around USD 2 billion, 10K+ clinical trials out of these, one leads to successful drug development.

Our Featured Drug Pipeline Reports

Prostate Cancer - Pipeline Review, H1 2018
Wet AMD- Pipeline Insight, 2018
Glioblastoma Multiforme (GBM) - Pipeline Review, H1 2018
Primary Biliary Cirrhosis - Pipeline Insight, 2018
Non-Small Cell Lung Cancer - Pipeline Review, H1 2018
Search Drug Pipeline Reports
Title Published Pages Price
Hepatocyte Growth Factor (Hepatopoietin A or Scatter Factor or HGF) - Pipeline Review, H2 2018 Sep 18 2018 73 USD 3,500.00
Uveitis - Pipeline Review, H2 2018 Sep 18 2018 207 USD 2,000.00
Nicotinamide Phosphoribosyltransferase (Visfatin or Pre B Cell Colony Enhancing Factor 1 or NAMPT or EC 2.4.2.12) - Pipeline Review, H2 2018 Sep 18 2018 53 USD 3,500.00
Bacterial Conjunctivitis - Pipeline Review, H2 2018 Sep 18 2018 35 USD 2,000.00
Estrogen Receptor (ER Alpha or Estradiol Receptor or Nuclear Receptor Subfamily 3 Group A Member 1 or NR3A1 or ESR1) - Pipeline Review, H2 2018 Sep 18 2018 83 USD 3,500.00
Psoriasis - Pipeline Review, H2 2018 Sep 18 2018 726 USD 2,500.00
Somatostatin Receptor Type 2 (SRIF1 or SSTR2) - Pipeline Review, H2 2018 Sep 18 2018 64 USD 3,500.00
Interstitial Cystitis (Painful Bladder Syndrome/Bladder Pain Syndrome) - Pipeline Review, H2 2018 Sep 18 2018 74 USD 2,000.00
Adrenocorticotropic Hormone Receptor (Adrenocorticotropin Receptor or Melanocortin Receptor 2 or ACTHR or MC2R) - Pipeline Review, H2 2018 Sep 18 2018 49 USD 3,500.00
Proliferative Diabetic Retinopathy (PDR) - Pipeline Review, H2 2018 Sep 18 2018 52 USD 2,000.00
Melanocyte Stimulating Hormone Receptor (Melanocortin Receptor 1 or MSHR or MC1R) - Pipeline Review, H2 2018 Sep 18 2018 59 USD 3,500.00
CD40 Ligand (T Cell Antigen Gp39 or TNF Related Activation Protein or Tumor Necrosis Factor Ligand Superfamily Member 5 or CD154 or CD40LG) - Pipeline Review, H2 2018 Sep 18 2018 60 USD 3,500.00
Melanin Concentrating Hormone Receptor 1 (G Protein Coupled Receptor 24 or MCH 1R or Somatostatin Receptor Like Protein or GPR24 or SLC1 or MCHR1) - Pipeline Review, H2 2018 Sep 18 2018 30 USD 3,500.00
Histone Deacetylase 1 (HDAC1 or EC 3.5.1.98) - Pipeline Review, H2 2018 Sep 18 2018 150 USD 3,500.00
Leber’s Hereditary Optic Neuropathy (Leber Optic Atrophy) - Pipeline Review, H2 2018 Sep 18 2018 86 USD 2,000.00
Cathepsin B (APP Secretase or Cathepsin B1 or CTSB or EC 3.4.22.1) - Pipeline Review, H2 2018 Sep 18 2018 32 USD 3,500.00
Choroidal Neovascularization - Pipeline Review, H2 2018 Sep 18 2018 51 USD 2,000.00
Glial Cell Line Derived Neurotrophic Factor (Astrocyte Derived Trophic Factor or GDNF) - Pipeline Review, H2 2018 Sep 18 2018 53 USD 3,500.00
Keratoconjunctivitis Sicca (Dry Eye) - Pipeline Review, H2 2018 Sep 18 2018 228 USD 2,000.00
Estrogen Receptor Beta (ER Beta or Nuclear Receptor Subfamily 3 Group A Member 2 or NR3A2 or ESR2) - Pipeline Review, H2 2018 Sep 18 2018 74 USD 3,500.00
Retinopathy Of Prematurity - Pipeline Review, H2 2018 Sep 18 2018 46 USD 2,000.00
Orexin Receptor Type 2 (Hypocretin Receptor Type 2 or HCRTR2) - Pipeline Review, H2 2018 Sep 18 2018 70 USD 3,500.00
Graft Versus Host Disease (GVHD) - Pipeline Review, H2 2018 Sep 18 2018 498 USD 2,000.00
Orexin Receptor Type 1 (Hypocretin Receptor Type 1 or HCRTR1) - Pipeline Review, H2 2018 Sep 18 2018 67 USD 3,500.00
Hyperuricemia - Pipeline Review, H2 2018 Sep 18 2018 67 USD 2,000.00
Proteinase Activated Receptor 2 (PAR2 or Coagulation Factor II Receptor Like 1 or G Protein Coupled Receptor 11 or Thrombin Receptor Like 1 or GPR11 or F2RL1) - Pipeline Review, H2 2018 Sep 18 2018 46 USD 3,500.00
Endometriosis - Pipeline Review, H2 2018 Sep 18 2018 135 USD 2,000.00
Transmembrane Prolyl 4 Hydroxylase (Hypoxia Inducible Factor Prolyl Hydroxylase 4 or P4HTM or EC 1.14.11.) - Pipeline Review, H2 2018 Sep 18 2018 62 USD 3,500.00
Lysophosphatidic Acid Receptor 1 (Lysophosphatidic Acid Receptor Edg 2 or LPAR1) - Pipeline Review, H2 2018 Sep 18 2018 36 USD 3,500.00
Histone Deacetylase 2 (Transcriptional Regulator Homolog RPD3 or YY1 Associated Factor 1 or HDAC2 or EC 3.5.1.98) - Pipeline Review, H2 2018 Sep 18 2018 128 USD 3,500.00

Clients Who Trust Us

Need tailor made market research solution? We can help you with that too.

About Us

At Market Research Reports, Inc. we aim to make it easier for decision makers to find relevant information and locate right market research reports which can save their time and assist in what they do best, i.e. take time-critical decisions.

We work with our associate Global market research firms who are known leaders in their respective domains to obtain right market research solution for our customer’s needs, be it custom research or syndicated research reports.

Contact Us

Market Research Reports, Inc
16192 Coastal Hwy
Lewes
, DE 19958, USA

USA: +1-302-703-9904

India: +91-8762746600

marketresearchreports

info@marketresearchreports.com

User login

Stay Connected